US Bancorp’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-479
| Closed | -$14.2K | – | 4152 |
|
|
2023
Q4 | $14.2K | Sell |
479
-41,488
| -99% | -$826K | ﹤0.01% | 3190 |
|
|
2023
Q3 | $666K | Buy |
41,967
+1,828
| +5% | +$30.4K | ﹤0.01% | 1225 |
|
|
2023
Q2 | $757K | Buy |
40,139
+39,912
| +17,582% | +$471K | ﹤0.01% | 1190 |
|
|
2023
Q1 | $872 | Hold |
227
| – | – | ﹤0.01% | 3897 |
|
|
2022
Q4 | $1.13K | Buy |
+227
| New | +$1.23K | ﹤0.01% | 3903 |
|
|
2022
Q1 | – | Sell |
-34
| Closed | – | – | 4248 |
|
|
2021
Q4 | $0 | Sell |
34
-473
| -93% | -$2.94K | ﹤0.01% | 4262 |
|
|
2021
Q3 | $3K | Buy |
507
+34
| +7% | +$196 | ﹤0.01% | 3836 |
|
|
2021
Q2 | $3K | Sell |
473
-203
| -30% | -$1.42K | ﹤0.01% | 3776 |
|
|
2021
Q1 | $5K | Buy |
676
+203
| +43% | +$1.66K | ﹤0.01% | 3521 |
|
|
2020
Q4 | $3K | Buy |
+473
| New | +$2.76K | ﹤0.01% | 3534 |
|
|
2020
Q1 | – | Sell |
-589
| Closed | -$3K | – | 3831 |
|
|
2019
Q4 | $3K | Buy |
589
+26
| +5% | +$88 | ﹤0.01% | 3429 |
|
|
2019
Q3 | $1K | Buy |
563
+432
| +330% | +$1.15K | ﹤0.01% | 3531 |
|
|
2019
Q2 | $0 | Sell |
131
-15,115
| -99% | -$35.7K | ﹤0.01% | 3694 |
|
|
2019
Q1 | $42K | Sell |
15,246
-130
| -0.8% | -$563 | ﹤0.01% | 2567 |
|
|
2018
Q4 | $74K | Sell |
15,376
-470
| -3% | -$2.85K | ﹤0.01% | 2272 |
|
|
2018
Q3 | $150K | Sell |
15,846
-42
| -0.3% | -$404 | ﹤0.01% | 2024 |
|
|
2018
Q2 | $155K | Hold |
15,888
| – | – | ﹤0.01% | 2010 |
|
|
2018
Q1 | $167K | Buy |
15,888
+888
| +6% | +$8.77K | ﹤0.01% | 1976 |
|
|
2017
Q4 | $96K | Hold |
15,000
| – | – | ﹤0.01% | 2286 |
|
|
2017
Q3 | $115K | Hold |
15,000
| – | – | ﹤0.01% | 2154 |
|
|
2017
Q2 | $107K | Sell |
15,000
-300
| -2% | -$1.37K | ﹤0.01% | 2158 |
|
|
2017
Q1 | $59K | Buy |
+15,300
| New | +$44.7K | ﹤0.01% | 2407 |
|
|
2016
Q3 | – | Sell |
-6,460
| Closed | -$20K | – | 3637 |
|
|
2016
Q2 | $20K | Buy |
6,460
+3,216
| +99% | +$20.2K | ﹤0.01% | 2804 |
|
|
2016
Q1 | $27K | Buy |
3,244
+3,118
| +2,475% | +$26.4K | ﹤0.01% | 2663 |
|
|
2015
Q4 | $2K | Sell |
126
-424
| -77% | -$5.22K | ﹤0.01% | 3463 |
|
|
2015
Q3 | $5K | Buy |
+550
| New | +$8.04K | ﹤0.01% | 3271 |
|
|
2015
Q1 | – | Sell |
-200
| Closed | -$1K | – | 3648 |
|
|
2014
Q4 | $1K | Sell |
200
-41
| -17% | -$375 | ﹤0.01% | 3476 |
|
|
2014
Q3 | $2K | Buy |
241
+41
| +21% | +$464 | ﹤0.01% | 3396 |
|
|
2014
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 3389 |
|
|
2014
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 3313 |
|
|
2013
Q4 | $3K | Sell |
200
-135
| -40% | -$2.08K | ﹤0.01% | 3248 |
|
|
2013
Q3 | $5K | Sell |
335
-1,892
| -85% | -$33.3K | ﹤0.01% | 3058 |
|
|
2013
Q2 | $37K | Buy |
+2,227
| New | +$36.1K | ﹤0.01% | 2431 |
|
Other funds holding IMGN
US Bancorp's IMGN Position: Q1 2024 in Review
US Bancorp sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 479 shares — an estimated $14.2K sold.
US Bancorp first reported a position in IMGN in Q2 2013 and held it in 33 quarters. The position peaked at $757K in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- US Bancorp reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- US Bancorp sold 479 Immunogen Inc shares in Q1 2024, an estimated $14.2K.
- US Bancorp first reported a position in Immunogen Inc in Q2 2013 and held it in 33 quarters.
- US Bancorp's Immunogen Inc position peaked at $757K in Q2 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on US Bancorp's 13F filing for Q1 2024, filed 8 May 2024.